Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
基本信息
- 批准号:10797470
- 负责人:
- 金额:$ 6.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinApoptosisApoptoticAutomobile DrivingAutophagocytosisAutophagosomeCASP1 geneCell DeathCell membraneCellsDNADouble-Stranded RNAEndoplasmic ReticulumGenesHomeostasisHost DefenseIRF3 geneImmuneImmune responseImmune signalingInflammasomeInflammationInflammatoryInflammatory ResponseInterferon Type IInvadedInvestigationLyticMacrophageMediatingMembraneMitochondriaMolecularNF-kappa BNatural ImmunityPathway interactionsPatternPattern recognition receptorPhosphorylationPhosphotransferasesPlayProductionProteinsRNA HelicaseRegulationRoleSignal PathwaySignaling ProteinStimulator of Interferon GenesTBK1 geneTestingTissuesViral GenomeVirusWorkZinc Fingersadaptive immune responseadaptive immunitycytokineds-DNAimmunoregulationinhibitorinsightnovelpathogenpathogenic microbeprotein aggregationreceptorrecruitresponsesensorubiquitin isopeptidase
项目摘要
ABSTRACT
Innate immunity provides the first line of host defense in response to invading pathogens. Pattern recognition
receptors (PRRs) sense pathogen-associated molecular patterns (PAMPs) in viruses and other pathogens.
RIG-I/MDA-5 are DExD/H box RNA helicases in the RIG-I-like receptor (RLR) pathway that detect double
stranded RNA viral genomes and activate the mitochondrial adaptor protein MAVS. The DNA sensor cGAS
detects double stranded DNA and activates STING, a transmembrane endoplasmic reticulum adaptor. Both
MAVS and STING activate canonical (IKKa and IKKb), and noncanonical IKK kinases (TBK1 and IKKi) to
activate transcription factors NF-kB and IRF3 respectively. Together, IRF3 and NF-kB regulate the expression
of type I interferon (IFN) and inflammatory genes that coordinate the innate response and initiate the adaptive
immune response against pathogens. The NLRP3 inflammasome also plays a critical role in inflammatory
responses by triggering caspase-1-mediated pro-IL-1b cleavage to yield the biologically active form of IL-
1b that drives inflammation and adaptive immunity. NLRP3 also induces a highly lytic form of inflammatory cell
death termed pyroptosis via cleavage of gasdermin-D to form plasma membrane pores. The RLR, cGAS-
STING and NLRP3 inflammasome pathways are potent inducers of inflammation that must be tightly regulated
to avert overexuberant inflammation and tissue damage. TAX1BP1 was first identified as an anti-apoptotic
protein that interacts with the zinc finger deubiquitinase A20/TNFAIP3. Our previous work has established that
TAX1BP1 restricts cytokine-induced NF-kB activation as well as RLR-induced type I IFN production and
apoptosis. TAX1BP1 functions as a selective autophagy receptor by recruiting ubiquitinated cargo to
developing autophagosomes via two LC3 interaction regions (LIRs). However, it remains unclear how
TAX1BP1 autophagy function is regulated and if TAX1BP1 inhibits other innate immune signaling pathways. In
preliminary studies we provide experimental evidence that TAX1BP1 is phosphorylated by both noncanonical
and canonical IKK kinases which controls both basal and virus-induced TAX1BP1 autophagic degradation
respectively. Using TAX1BP1-deficient macrophages we have demonstrated that TAX1BP1 is a novel inhibitor
of both cGAS-STING and NLRP3 pathways. Furthermore, MAVS protein aggregates accumulate in TAX1BP1-
deficient cells suggesting a potential aggrephagy function in the regulation of innate immune signaling. The
central hypothesis driving the proposed investigations is that TAX1BP1 inhibits RLR, cGAS-STING and NLRP3
pathways by autophagy-mediated clearance of signaling protein aggregates. We will test this hypothesis
experimentally with the following Specific Aims: (1) determine the role of TAX1BP1 phosphorylation in its
autophagy function, (2) determine the mechanisms of TAX1BP1 inhibition of the cGAS-STING pathway, and
(3) determine the mechanisms of TAX1BP1 inhibition of the NLRP3 pathway. Completion of the proposed
studies will provide new insights into innate immune regulation and immune homeostasis.
抽象的
先天免疫提供了宿主应对入侵病原体的第一道防线。模式识别
受体(PRR)感知病毒和其他病原体中的病原体相关分子模式(PAMP)。
RIG-I/MDA-5 是 RIG-I 样受体 (RLR) 通路中的 DExD/H 盒 RNA 解旋酶,可检测双
链RNA病毒基因组并激活线粒体接头蛋白MAVS。 DNA 传感器 cGAS
检测双链 DNA 并激活 STING(一种跨膜内质网接头)。两个都
MAVS 和 STING 激活经典(IKKa 和 IKKb)和非经典 IKK 激酶(TBK1 和 IKKi)
分别激活转录因子 NF-kB 和 IRF3。 IRF3 和 NF-kB 共同调节表达
I 型干扰素 (IFN) 和炎症基因协调先天反应并启动适应性
针对病原体的免疫反应。 NLRP3炎症小体在炎症反应中也发挥着关键作用
通过触发 caspase-1 介导的 pro-IL-1b 裂解产生具有生物活性形式的 IL-
1b 驱动炎症和适应性免疫。 NLRP3 还诱导高度溶解形式的炎症细胞
通过gasdermin-D 裂解形成质膜孔而导致的死亡被称为细胞焦亡。 RLR、cGAS-
STING 和 NLRP3 炎症小体通路是炎症的有效诱导物,必须受到严格调控
以避免过度炎症和组织损伤。 TAX1BP1 首次被鉴定为抗凋亡药物
与锌指去泛素酶 A20/TNFAIP3 相互作用的蛋白质。我们之前的工作已经确定
TAX1BP1 限制细胞因子诱导的 NF-kB 激活以及 RLR 诱导的 I 型 IFN 产生和
细胞凋亡。 TAX1BP1 通过招募泛素化货物来发挥选择性自噬受体的作用
通过两个 LC3 相互作用区域 (LIR) 形成自噬体。然而,目前尚不清楚如何
如果 TAX1BP1 抑制其他先天免疫信号通路,则 TAX1BP1 自噬功能受到调节。在
初步研究我们提供了 TAX1BP1 被非规范磷酸化的实验证据
以及控制基础和病毒诱导的 TAX1BP1 自噬降解的经典 IKK 激酶
分别。使用 TAX1BP1 缺陷型巨噬细胞,我们证明了 TAX1BP1 是一种新型抑制剂
cGAS-STING 和 NLRP3 通路。此外,MAVS 蛋白聚集体在 TAX1BP1- 中积累
缺陷细胞表明在先天免疫信号调节中具有潜在的聚合吞噬功能。这
推动拟议研究的中心假设是 TAX1BP1 抑制 RLR、cGAS-STING 和 NLRP3
通过自噬介导的信号蛋白聚集体清除途径。我们将检验这个假设
实验具有以下具体目标:(1)确定 TAX1BP1 磷酸化在其
自噬功能,(2) 确定 TAX1BP1 抑制 cGAS-STING 通路的机制,以及
(3)确定TAX1BP1抑制NLRP3通路的机制。完成拟议的
研究将为先天免疫调节和免疫稳态提供新的见解。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD W HARHAJ其他文献
EDWARD W HARHAJ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD W HARHAJ', 18)}}的其他基金
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression
KDR/VEGFR2 对 HTLV-1 肿瘤发生和病毒基因表达的调节
- 批准号:
10610829 - 财政年份:2022
- 资助金额:
$ 6.68万 - 项目类别:
KDR/VEGFR2 regulation of HTLV-1 oncogenesis and viral gene expression
KDR/VEGFR2 对 HTLV-1 肿瘤发生和病毒基因表达的调节
- 批准号:
10353507 - 财政年份:2022
- 资助金额:
$ 6.68万 - 项目类别:
AIP inhibition of IRF7 and innate antiviral signaling
AIP 抑制 IRF7 和先天抗病毒信号
- 批准号:
10217831 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10276931 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10622514 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
AIP inhibition of IRF7 and innate antiviral signaling
AIP 抑制 IRF7 和先天抗病毒信号
- 批准号:
10393620 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1
选择性自噬受体 TAX1BP1 对先天免疫信号通路的负调节
- 批准号:
10414107 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
ZFAND6 regulation of innate antiviral immunity
ZFAND6 对先天抗病毒免疫的调节
- 批准号:
9979076 - 财政年份:2020
- 资助金额:
$ 6.68万 - 项目类别:
The role of TAX1BP1 in the innate immune response to virus infection
TAX1BP1在病毒感染先天免疫反应中的作用
- 批准号:
8998913 - 财政年份:2015
- 资助金额:
$ 6.68万 - 项目类别:
Mechanisms of HTLV-I Tax-mediated NF-kB activation
HTLV-I Tax 介导的 NF-kB 激活机制
- 批准号:
8210991 - 财政年份:2009
- 资助金额:
$ 6.68万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 6.68万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 6.68万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 6.68万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 6.68万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 6.68万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 6.68万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 6.68万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 6.68万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 6.68万 - 项目类别:














{{item.name}}会员




